Autocrine motility factor and its receptor expression in musculoskeletal tumors

Kosei Nakajima1,2, Avraham Raz3

  • 1Division of Translational Research, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-Ku, Tokyo 104-0045, Japan.

Journal of Bone Oncology
|October 26, 2020
PubMed

Insights

Autocrine motility factor (AMF) and its receptor (AMFR) signaling drives aggressive musculoskeletal tumors. Inhibiting AMF and AMFR presents a potential therapeutic strategy for these challenging cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Aggressive malignant musculoskeletal tumors pose significant clinical challenges.
  • Autocrine motility factor (AMF) and its receptor (AMFR) signaling are implicated in tumor progression by altering the bone microenvironment.
  • AMF/GPI and AMFR/gp78 are moonlighting proteins involved in cellular metabolism and protein degradation, contributing to increased metabolic turnover.

Purpose of the Study:

  • To review the role of AMF-AMFR signaling in malignant musculoskeletal tumors.
  • To highlight the potential of targeting AMF and AMFR as a therapeutic strategy.
  • To underscore the unmet medical need for novel treatments in this area.

Main Methods:

  • Literature review of studies on AMF and AMFR in musculoskeletal tumors.
  • Analysis of a large-scale cohort study examining AMF and AMFR expression in various tumor types.
  • Examination of cellular data linking tumor cells and bone microenvironment components via AMF-AMFR signaling.

Main Results:

  • Musculoskeletal tumors, including osteosarcoma and multiple myeloma, show elevated AMF expression.
  • Multiple myeloma patients exhibit high AMFR expression.
  • Cellular data confirms AMF expression in tumors and AMFR expression in the bone microenvironment, indicating cross-talk.

Conclusions:

  • AMF-AMFR signaling represents a critical link between musculoskeletal tumors and the skeletal environment.
  • Pharmacological inhibition of AMF and AMFR is a promising therapeutic avenue.
  • Targeting this pathway addresses a significant unmet medical need in managing aggressive malignant musculoskeletal tumors.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.4K
Role of Myosin in Cell Migration01:18

Role of Myosin in Cell Migration

Myosins are multimeric motor proteins involved in various cellular processes such as migration, adhesion, and proliferation. Myosin II is the most common type in animal cells, which binds and cross-links actin filaments.
Myosin II  is a hexamer comprising two heavy chains with globular heads and coiled-coil tails, two regulatory light chains, and two essential light chains. The ATPase sites on the myosin heads hydrolyze ATP, and the released phosphate generates the force for contraction....
2.9K
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.2K
Cytoskeletal Coordination in Cell Migration01:32

Cytoskeletal Coordination in Cell Migration

A migrating cell changes its shape during the cyclic events of attachment and detachment from the substratum and repositions the cell organelles correspondingly. These complex events are orchestrated by the dynamic cytoskeletal network comprising actin filaments, intermediate filaments, and microtubules. Cytoskeletal crosstalk — the direct and indirect communication between the different components — is crucial for this coordination. Direct communication involves various linker...
5.2K
Microtubules in Cell Motility01:24

Microtubules in Cell Motility

Microtubules are thick hollow cylindrical proteins that help form the cytoskeleton. Microtubules have varied roles in the cell. These filaments help form cellular appendages like cilia and flagella, which are responsible for locomotion. The cilia arise from basal bodies, separated from the main body by a membrane-like structure forming the transition zone. This zone is the gate for the entry of lipids and proteins, creating a unique composition of lipids and proteins in the ciliary membrane and...
4.3K